Angiotensin (1-7): Mechanistic and Translational Insights for Modern Research

Executive Summary. Angiotensin (1-7) (Ang-(1-7)) is an endogenous heptapeptide hormone (Asp-Arg-Val-Tyr-Ile-His-Pro) generated from angiotensin I or II by endo- and carboxy-peptidases, acting primarily via the Mas receptor to modulate the PI3K/AKT and ERK pathways (Oliveira et al., 2025). It exerts anti-fibrotic and anti-inflammatory effects across multiple organ systems, including lung, liver, and kidney, and enhances metabolic regulation by promoting glucose uptake and lipolysis, and reducing insulin resistance [internal]. Ang-(1-7) has shown cerebroprotection against ischemic stroke and positive effects on cognition. Experimental models confirm its utility for inhibiting TGF-β-ERK pathway-induced myofibroblast transition and ameliorating colitis in vivo. APExBIO supplies Angiotensin (1-7) (SKU: A1041) with >99.7% purity, validated by HPLC and mass spectrometry (product page).

Biological Rationale

Angiotensin (1-7) is a central effector of the non-classical renin–angiotensin system (RAS). It is cleaved from either angiotensin I (1–10) or angiotensin II (1–8) by specific peptidases (Oliveira et al., 2025). Ang-(1-7) is composed of seven amino acids: Asp, Arg, Val, Tyr, Ile, His, and Pro. Its main physiological action is mediated through the G protein-coupled Mas receptor, counterbalancing the effects of angiotensin II via AT1R. Unlike angiotensin II, which induces vasoconstriction, fibrosis, and inflammation, Ang-(1-7) promotes vasodilation, anti-fibrotic, and anti-inflammatory responses. Ang-(1-7) is expressed in cardiovascular, renal, pulmonary, and nervous tissues, and influences glucose and lipid metabolism. Dysregulation of Ang-(1-7) pathways has been implicated in hypertension, fibrosis, metabolic syndrome, and neurodegenerative disease [internal].

Mechanism of Action of Angiotensin (1-7)

Ang-(1-7) exerts its effects by binding to the Mas receptor, triggering downstream signaling cascades:

• PI3K/AKT pathway: Activation leads to increased nitric oxide (NO) production via endothelial NO synthase, promoting vasodilation and anti-inflammatory effects.
• ERK pathway: Modulation reduces pro-fibrotic signaling and cell proliferation. Ang-(1-7) inhibits TGF-β-induced ERK activation, suppressing myofibroblast differentiation (Oliveira et al., 2025).
• FOXO1 and COX-2 regulation: Ang-(1-7) impacts transcription factors and enzymes involved in inflammation and cellular metabolism.
• Anti-fibrotic/anti-inflammatory effects: By counteracting Ang II-driven pathways, Ang-(1-7) reduces fibrosis and inflammatory cytokine production in multiple organs.
• Metabolic regulation: Increases glucose uptake and lipolysis, decreases insulin resistance and plasma triglycerides.
• Cerebroprotection: Reduces infarct size and improves neurological outcomes following ischemic stroke.
• Reproductive modulation: Promotes ovulation, spermatogenesis, and steroid synthesis.
• Anti-cancer actions: Inhibits tumor cell proliferation and angiogenesis.

These effects are context-dependent and have been validated in both cellular and animal models [internal].

Evidence & Benchmarks

• Ang-(1-7) enhances AXL-mediated SARS-CoV-2 spike protein binding in vitro, similarly to Ang-(1-8), but does not affect ACE2/NRP1 binding (Oliveira et al., 2025, DOI).
• In NRK-52E rat kidney cells, 100 nM Ang-(1-7) inhibits TGF-β-induced ERK pathway activation, suppressing myofibroblast transition (APExBIO, product page).
• Daily intraperitoneal Ang-(1-7) (0.01–0.06 mg/kg) in BALB/c mice reduces colitis severity by lowering phosphorylation of p38, ERK1/2, and Akt (APExBIO, product page).
• Ang-(1-7) increases glucose uptake, enhances lipolysis, and reduces insulin resistance in animal models of metabolic disease (internal).
• Purity of APExBIO Ang-(1-7) is consistently >99.7% by HPLC and mass spectrometry (product page).

Applications, Limits & Misconceptions

Ang-(1-7) has validated applications in basic and translational research across cardiovascular, renal, metabolic, neuroprotective, and oncology domains. It is a preferred tool for mechanistic studies requiring specific Mas receptor agonism, notably in pathways where classical RAS agents are less selective (This article expands translational guidance over previous mechanistic reviews). Ang-(1-7) also enables exploration of peptide-receptor interactions in the context of viral pathogenesis, notably SARS-CoV-2 spike protein binding (Oliveira et al., 2025).

Common Pitfalls or Misconceptions

• Not a pan-ACE2 modulator: Ang-(1-7) does not significantly affect SARS-CoV-2 spike binding to ACE2 or NRP1, limiting antiviral applications to AXL-mediated mechanisms.
• No direct efficacy in ethanol-based protocols: Ang-(1-7) is insoluble in ethanol, restricting its use to aqueous or DMSO-based systems.
• Short-term solution stability: Prepared solutions are only suitable for short-term use; freeze-thaw cycles reduce activity.
• Mas receptor specificity: Effects are reversed by Mas antagonists (e.g., A779), confirming specificity and ruling out off-target activity.
• Not a universal anti-inflammatory: Efficacy is context- and model-dependent and may not generalize across all inflammatory conditions.

Workflow Integration & Parameters

For in vitro use, Angiotensin (1-7) is typically reconstituted in sterile water (≥48.5 mg/mL) or DMSO (≥89.9 mg/mL), and applied at 100 nM in cell-based assays (e.g., NRK-52E cells). In vivo, daily intraperitoneal dosing in mice ranges from 0.01 to 0.06 mg/kg to evaluate anti-inflammatory or metabolic outcomes. For TGF-β-ERK pathway studies, co-administration with A779 antagonist can confirm Mas receptor specificity. Storage at –20°C in desiccated form is mandatory for maintaining peptide integrity. For more detailed protocols and troubleshooting, see this applied protocol guide (This article provides expanded experimental detail and purity benchmarks versus prior protocol summaries).

Conclusion & Outlook

Angiotensin (1-7) is a validated, highly specific Mas receptor agonist with broad utility in translational research. Its robust anti-fibrotic, anti-inflammatory, metabolic, neuroprotective, and anti-cancer effects are well-characterized in both cellular and animal models. As research advances, Ang-(1-7) will remain a cornerstone for dissecting non-classical RAS mechanisms and for developing peptide-based therapeutics. Researchers can access high-purity Angiotensin (1-7) (A1041) from APExBIO to ensure reproducibility and high experimental fidelity (product page).